TNF and rheumatoid arthritis: In a multicenter, retrospective study, RA patients initially treated with abatacept (n = 76, most of them discontinued abatacept due to lack of effectiveness) were switched to either TNF inhibitors (adalimumab, certolizumab pegol, etanercept, golimumab, infliximab) or tocilizumab.